ABSTRACT
Objective: Despite recent progress in caring for patients born with esophageal atresia (EA), undernutrition and stunting remain common. Our study objective was to assess nutritional status in the first year after birth with EA and to identify factors associated with growth failure. Study design: We conducted a population-based study of all infants born in France with EA between 2010 and 2016. Through the national EA register, we collected prenatal to 1 year follow-up data. We used body mass index and length-for-age ratio Z scores to define patients who were undernourished and stunted, respectively. Factors with P < 0.20 in univariate analyses were retained in a logistic regression model. Results: Among 1,154 patients born with EA, body mass index and length-for-age ratio Z scores at 1 year were available for about 61%. Among these, 15.2% were undernourished and 19% were stunted at the age of 1 year. There was no significant catch-up between ages 6 months and 1 year. Patients born preterm (41%), small for gestational age (17%), or with associated abnormalities (55%) were at higher risk of undernutrition and stunting at age 1 year (P < 0.05). Neither EA type nor surgical treatment was associated with growth failure. Conclusion: Undernutrition and stunting are common during the first year after birth in patients born with EA. These outcomes are significantly influenced by early factors, regardless of EA type or surgical management. Identifying high-risk patient groups with EA (i.e., those born preterm, small for gestational age, and/or with associated abnormalities) may guide early nutritional support strategies.
ABSTRACT
OBJECTIVE: To identify predictors of and factors associated with the performance of antireflux surgery during the first year of life in children born with esophageal atresia. STUDY DESIGN: All patients were included in a French registry for esophageal atresia. All 38 multidisciplinary French centers completed questionnaires about perinatal characteristics and one-year outcome for children born with esophageal atresia. RESULTS: Of 835 infants with esophageal atresia born in France from 2010 to 2014, 682 patients, excluding those with long-gap esophageal atresia, were included. Three patients had type I, 669 had type III, and 10 had type IV esophageal atresia. Fifty-three children (7.8%) received fundoplication during the first year of life. The median age at the time of the end-to-end esophageal anastomosis was 1.1 day (range 0-15). Multivariate analysis identified three perioperative factors that predicted the need for early antireflux surgery: anastomotic tension (P = .004), associated malformations (P = .019), and low birth weight (P = .018). Six other factors, measured during the first year of life, were associated with the need for antireflux surgery: gastroesophageal reflux (P < .001), anastomotic stricture (P < .001), gastrostomy (P < .001), acute life-threatening event (P = .002), respiratory complications (P = .045), and poor nutritional status (P < .001). CONCLUSIONS: Gastroesophageal reflux disease, low birth weight, poor nutrition, and surgical anastomosis difficulties predicted the performance of antireflux surgery in the first year of life in infants with esophageal atresia.
Subject(s)
Esophageal Atresia/surgery , Fundoplication , Anastomosis, Surgical/adverse effects , Constriction, Pathologic , Esophageal Atresia/classification , Female , France , Gastroesophageal Reflux/surgery , Gastrostomy , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Male , Multivariate Analysis , Nutritional Status , RegistriesABSTRACT
INTRODUCTION: Nephrogenic adenoma (NA) of the bladder is a rare transitional cell tumour of the bladder in children under the age of 10 years. The objective of this study was to report our experience and review the data of the literature in order to define a coherent therapeutic approach. PATIENTS AND METHODS: We report 5 cases of NA diagnosed between 1995 and 2003 in 3 boys and 2 girls with a mean age of 6.38 years and a mean follow-up of 7.1 years. RESULTS: All patients presented a risk factor for bladder irritation. Initial symptoms were nonspecific and radiology contributed to the diagnosis in two cases. Treatment was performed by transurethral resection (3 cases) or cystotomy (2 cases). One recurrence was observed 8 years after the initial diagnosis, but no cases of malignant transformation were observed during follow-up. CONCLUSION: NA of the bladder is a benign tumour which does not predispose to malignancy. The initial treatment consisted of endoscopic resection combined with elimination of risk factors. Despite the frequency of recurrence, endoscopic surveillance does not appear to be justified. Urine cytology could contribute to the diagnosis of recurrence.